High-level vancomycin-resistant enterococci causing hospital infections - Wikidata - awgldk - TriplyDB

High-level vancomycin-resistant enterococci causing hospital infections

High-level vancomycin-resistant enterococci causing hospital infections

http://www.wikidata.org/entity/Q36473265

about

Identification of Enterococcus species and phenotypically similar Lactococcus and Vagococcus species by reverse checkerboard hybridization to chaperonin 60 gene sequences Comparison of genomic methods for differentiating strains of Enterococcus faecium: assessment using clinical epidemiologic data.Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients.Genetic diversity among Enterococcus faecalis Phenotypic and genotypic characterization of nosocomial Staphylococcus aureus isolates from trauma patients.Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The Grupo Andaluz para el estudio de las Enfermedades Infecciosas.Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus.Evaluation of empiric vancomycin therapy in children with fever and neutropenia.Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period.Outbreak of vancomycin-resistant enterococci in a hospital in Gdask, Poland, due to horizontal transfer of different Tn1546-like transposon variants and clonal spread of several strains.Vancomycin-resistant Enterococcus faecium strain carrying the vanB2 gene variant in a Polish hospital.Outbreak of vancomycin-resistant Enterococcus faecium of the phenotype VanB in a hospital in Warsaw, Poland: probable transmission of the resistance determinants into an endemic vancomycin-susceptible strain.Molecular characterization of glycopeptide-resistant enterococci from hospitals of the picardy region (france).Vancomycin-resistant enterococci: mechanisms and clinical observations.Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: prospective study.A clonal lineage of VanA-type Enterococcus faecalis predominates in vancomycin-resistant Enterococci isolated in New Zealand.Antimicrobial-resistant, Gram-positive bacteria among patients undergoing chronic hemodialysis.In vitro activity of A-86719.1, a novel 2-pyridone antimicrobial agent Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic.Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States.In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide Current perspectives on glycopeptide resistance.Emergence and nosocomial transmission of ampicillin-resistant enterococci.Glycopeptide resistance in gram-positive cocci: a review.Vancomycin gene selection in the microbiome of urban Rattus norvegicus from hospital environment.Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA).Susceptibility of enterococci and epidemiology of enterococcal infection in the 1980s Characterization of enterococcal isolates by restriction enzyme analysis of genomic DNA.Implementation of antibiotic management teams in Belgian hospitals.Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.Comparison of rectal and perirectal swabs for detection of colonization with vancomycin-resistant enterococci Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci.Resistance to vancomycin and teicoplanin: an emerging clinical problem.Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.CRISPR-Cas and Restriction-Modification Act Additively against Conjugative Antibiotic Resistance Plasmid Transfer in Enterococcus faecalis.Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci.Oritavancin: a new promising agent in the treatment of infections due to Gram-positive pathogens.Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states.

P2860

Q24550840-EA32D9A5-C062-42BE-ADDA-BB7DC64C5B0B Q31998538-B8FEBD19-A817-4E34-B5F7-361411C3A3E6 Q33254698-0A6D94EC-1CE4-4AD3-9078-8661B4C7A8B9 Q33289954-07D4364C-4A82-4418-AA7B-672A37EEFCE0 Q33656004-1DF78BED-2F25-487A-AC95-E0FEAD584F91 Q33656986-B17A548E-AB49-4B0E-B125-7867488B0826 Q33755826-9A96D9B2-F43B-4479-A55F-C7E280B39CD5 Q33771365-D8AA4F96-1E8F-4093-8222-DDA9527AC603 Q33964133-B752A271-A859-4B7E-A784-DE73B0EFF344 Q33969618-137319F8-D199-492D-B0F9-1BBDFCFC123C Q33971412-0482FF8B-CAC7-4E8F-9956-AA2237C142D0 Q33972211-44F2AE50-2238-4D63-9533-1359D6A03B81 Q34259945-6596D749-C98F-4D67-B7CE-D656C82B9363 Q34289227-51B84D6B-42CB-4A28-9E42-B7952843102F Q34683565-DAF64AAB-2B17-41FD-9440-DA46C46EAFCC Q34724687-386E0E66-451A-446D-B085-90262E433B6F Q34985828-3680DB90-4513-4B45-B790-6181E0C26105 Q35113155-30F4E56A-1922-46D0-9844-7B97BA979F1C Q35116375-1BB2CDB1-0B0A-4846-8FB3-59AF3D9E5131 Q35129398-67C1E962-34AF-4627-8F3A-80FF35A4C9C0 Q35138478-2A9BC182-2F96-46B8-8A3D-82CDE8E3C17A Q35368590-A544C7E3-FA39-4D3E-84C8-C782A157183D Q35836173-FFCB0AD4-A2BC-4830-8DC1-47C9531ACDBB Q36072225-FF61754D-869E-4B4F-9FB8-41FB18A6F571 Q36076898-C0CD23CB-5776-4724-A5D8-21465C8696A2 Q36315377-060F2EDA-07D5-493D-9ABD-BBFAF941FBB2 Q36473436-22D585EE-7698-4401-8348-73A1F7678BDC Q36506078-CFB0D21E-2B9D-439F-8E19-15EB8C995623 Q36515260-E92A4FF5-69A5-4C36-8A66-2E1E2A072FE2 Q36516947-C34F7882-4D5D-495D-98FC-8879C5FA267F Q36527555-8D8F7D0F-77A4-4F94-9E47-DBD24DF9436B Q36543611-68AC56BC-1695-42F3-9EBE-64C9FAA87FFF Q36636341-C08E3CF5-BED9-46F2-89DF-601CC90F95CC Q36752594-4275CB09-1D9E-4CEB-A53F-FD7710BE244B Q36754480-1FA6A276-607C-4E92-BC36-F705991B2C30 Q36973145-636A3038-9FCC-4D27-B7FA-B8E702B72BE7 Q37066214-1A0C41DF-A77B-4610-B070-16308C6F771D Q37071199-62A30A22-4197-4FD3-9AA8-667A873462DB Q37126795-A4AE539F-3506-44F2-A31B-F5DE1D1F0B6B Q37128627-F75722FA-EB8A-462E-AF79-6AD92824E44E

P2860

High-level vancomycin-resistant enterococci causing hospital infections

http://www.wikidata.org/entity/Q36473265

description

1989 nî lūn-bûn

@nan

1989年の論文

@ja

1989年学术文章

@wuu

1989年学术文章

@zh-cn

1989年学术文章

@zh-hans

1989年学术文章

@zh-my

1989年学术文章

@zh-sg

1989年學術文章

@yue

1989年學術文章

@zh

1989年學術文章

@zh-hant

name

High-level vancomycin-resistant enterococci causing hospital infections

@ast

High-level vancomycin-resistant enterococci causing hospital infections

@en

type

label

High-level vancomycin-resistant enterococci causing hospital infections

@ast

High-level vancomycin-resistant enterococci causing hospital infections

@en

prefLabel

High-level vancomycin-resistant enterococci causing hospital infections

@ast

High-level vancomycin-resistant enterococci causing hospital infections

@en

P1433

Q36473265-75D00D0A-F365-4837-8251-5396AFCCE4D1

P1476

Q36473265-86D21ABA-41BC-407F-8047-98FC6C546549

P2093

Q36473265-0A94539C-7B20-4263-9CD5-2EB619FE17EE

Q36473265-12420BE3-CC6D-41AC-8C43-32C3CC59F904

Q36473265-1F2E0ABB-372F-4691-8578-FF4C92901CF6

Q36473265-607D6E52-9316-46FC-88B8-F1BA5C22B1DC

Q36473265-9A5CA355-8D1E-4F87-AF3B-B810C8CF3294

Q36473265-B6E54A8C-FFEB-4454-8812-E30F981488DA

Q36473265-C4D6E308-CD71-47CE-92DA-159C0A5E3B1A

Q36473265-CFFEC813-F0BA-49E1-8008-CFD8E1BA0DD4

Q36473265-E77D8BB8-5CB1-4FF5-87B2-C3A887EEDC87

Q36473265-F14A5D3A-5DE0-4B06-A5C7-7B1AE78E7AF8

P2860

Q36473265-00BB7297-9CE5-473C-ABED-5A05EF910810

Q36473265-01576CAB-D9BE-4281-BA0A-2BE1BA9DAF2B

Q36473265-10FCE031-E1C0-4CF1-94AE-F7892E390013

Q36473265-4DF35DEA-D632-4CE2-ABA4-43F123EC54FA

Q36473265-50DA48F3-DC96-4631-83F3-D0C565690401

Q36473265-51B96931-C43E-49BD-8A97-719D88408F17

Q36473265-65181F08-51C3-49DE-AE99-09E042EF272D

Q36473265-6C13F94A-ABB3-4D16-98E2-26AE30CEF19D

Q36473265-7D42FB5C-A753-487E-8ADB-B6566C9F4455

Q36473265-7F2B0DE1-3E5B-422D-AFE4-1168D9DD613D

P304

Q36473265-1562D330-405F-4D6F-B802-032CEE6F86DF

P31

Q36473265-3AAB4269-1740-43F9-A270-F80EADDC9136

P356

Q36473265-D1FB067A-32C9-437A-B5B2-B544E3F24C26

P433

Q36473265-571C91CA-837C-4677-8A64-D0AA60E2C7FF

P478

Q36473265-023BD690-87DE-4CD3-A956-1F89AA8D60F5

P577

Q36473265-862248B5-A14C-49B7-B66E-5AF238590975

P698

Q36473265-357F0DED-D6C8-4909-8DF3-FD8247B99504

P932

Q36473265-6960DAA6-D6A5-47F7-99ED-8E14F7518BEB

P356

S0950268800030478

P1433

Epidemiology and Infection

P1476

High-level vancomycin-resistant enterococci causing hospital infections

@en

P2093

Collins CH

http://www.w3.org/2001/XMLSchema#string

Fitch LE

http://www.w3.org/2001/XMLSchema#string

George RC

http://www.w3.org/2001/XMLSchema#string

Gilfillan AJ

http://www.w3.org/2001/XMLSchema#string

Heptonstall J

http://www.w3.org/2001/XMLSchema#string

Johnson AP

http://www.w3.org/2001/XMLSchema#string

Morrison D

http://www.w3.org/2001/XMLSchema#string

Naidoo J

http://www.w3.org/2001/XMLSchema#string

Uttley AH

http://www.w3.org/2001/XMLSchema#string

Woodford N

http://www.w3.org/2001/XMLSchema#string

P2860

Nosocomial urinary tract infections due to enterococcus. Ten years' experience at a university hospital.

Transferable vancomycin and teicoplanin resistance in Enterococcus faecium.

Evidence for a chromosome-borne resistance transposon (Tn916) in Streptococcus faecalis that is capable of "conjugal" transfer in the absence of a conjugative plasmid.

Common occurrence of plasmid DNA and vancomycin resistance in Leuconostoc spp

The Enterococci and Related Streptococci.

Evaluation of teicoplanin and vancomycin disk susceptibility tests.

Conjugative transposons and the dissemination of antibiotic resistance in streptococci.

The enterococcus: "putting the bug in our ears".

Recovery of resistant enterococci during vancomycin prophylaxis.

Treatment failures secondary to in vivo development of drug resistance by microorganisms.

P304

173-181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S0950268800030478

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

1989-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2506070

http://www.w3.org/2001/XMLSchema#string

P932

2249484

http://www.w3.org/2001/XMLSchema#string